The Tuberculosis Diagnostics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Tuberculosis Diagnostics Market?
The Tuberculosis Diagnostics Global Market Report 2025 has shown a strong growth trend. The market size has increased from $2.21 billion in 2024 to $2.36 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Tuberculosis Diagnostics Industry?
The Tuberculosis Diagnostics Global Market Report 2025 predicts that by 2029, the Tuberculosis Diagnostics market will have grown to $3.24 billion with a Compound Annual Growth Rate (CAGR) of 8.2%.
Download Your Free Sample of the 2025 Tuberculosis Diagnostics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Tuberculosis Diagnostics Market?
The key drivers in the tuberculosis diagnostics market are:
• Strong government support for tuberculosis diagnostics
• Increasing FDA approvals for tuberculosis diagnostics
• Rising research and development activities in the field
• Emergence of drug-resistant TB driving the need for advanced diagnostics
Global Market Segmentation: Identifying Major Tuberculosis Diagnostics Industry Segments
The tuberculosis diagnostics market covered in this report is segmented –
1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities
Pre-order the 2025 Tuberculosis Diagnostics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Tuberculosis Diagnostics Market?
The key trends in the tuberculosis diagnostics market are:
• There is a growing focus on the use of next-Generation Sequencing (NGS) platforms for TB diagnostics.
• Innovations in product development are a major emerging trend in the market.
• T-cell testing for TB infection is becoming a more prevalent diagnostic method.
• There is a notable increase in the use of Artificial Intelligence (AI) based tuberculosis diagnostics and portable devices.
Who Are the Top Competitors & Leading Players in the Tuberculosis Diagnostics Market?
Major companies in the tuberculosis diagnostics market are:
• Beckton, Dickinson and Company
• F. Hoffmann-La Roche Ltd
• Qiagen N.V
• BioMerieux SA
• Danaher Corporation
• PerkinElmer
• Thermo Fisher Scientific Inc.
• Creative Diagnostics
• Lionex GmbH
• Biocartis
• Bio-Techne India Private Limited
• Bio-Rad laboratories India Pvt.Ltd
• Zhejiang Di'an Diagnostics Technology Co., Ltd
• ADICON Clinical Laboratories
• Guangzhou Kingmed Diagnostics Center Co. Ltd.
• Kindstar Global
• OriGene Technologies
• Siemens AG
• LumiraDx Limited
• TestLine Clinical Diagnostics s.r.o.
• Hologic
• Bayer AG
• Meridian Bioscience
• Abbott laboratories Immunodiagnostic Systems Holdings PLC
• Mesa Biotech Inc
• Agilent technologies Inc
• Akonni Biosystems Inc
• Epistem Limited
• Gen-Probe
• Sysmex South Africa (Pty) Ltd.
• Bio Certica
• BixBio
Regional Dominance: Which Area Leads the Global Template Market?
Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024
